(9) Drug screens.(a) Drug screen sample collection policies intended to prevent falsification shall be developed and followed.(b) Drug screens shall be analyzed for the following drugs:1. Approved controlled substance;2. Cocaine;3. Opiates;4. Amphetamines;5. Barbiturates;6. Tetrahydrocannabinol;7. Benzodiazepines;8. Any other drug or drugs that has been determined by the NTP or the SNA to be abused in that program's locality; and9. Any other drugs that could have been abused by the client.(c) Drug screens shall be reviewed by the treatment team monthly to determine the client's reduction in the use of unauthorized medications.(d) Controlled substance medications shall be considered unapproved usage if they are being used by the client without a valid prescription.(e) A drug screen that is negative for the approved controlled substances allowed to be used in the NTP shall be considered positive for unauthorized drug use.(f) An NTP shall not use drug screens as the sole criteria for involuntarily terminating a client's participation in the program.(g) When drug screening results are used, presumptive laboratory results shall be distinguished in the client record from results that are definitive.(h) Samples used for drug screening purposes shall be handled in a manner that ensures client confidentiality.
see full law